Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study

Published:2016-06-09 Issue:11 Volume:16 Page:3192-3201
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Durrbach A.¹²,Pestana J. M.³,Florman S.⁴,del Carmen Rial M.⁵,Rostaing L.⁶,Kuypers D.⁷,Matas A.⁸,Wekerle T.⁹,Polinsky M.¹⁰,Meier-Kriesche H. U.¹⁰,Munier S.¹¹,Grinyó J. M.¹²

Affiliation:

1. University Hôpital of Bicêtre; Le Kremlin-Bicêtre France

2. Université Paris-Saclay; Plateau de Saclay France

3. Hospital do Rim; Sao Paulo Brazil

4. Mount Sinai Medical Center; New York NY

5. Instituto de Nefrología; Buenos Aires Argentina

6. University Hospital; Toulouse France

7. University Hospitals Leuven; Leuven Belgium

8. University of Minnesota; Minneapolis MN

9. Medical University of Vienna; Vienna Austria

10. Bristol-Myers Squibb; Lawrenceville NJ

11. Bristol-Myers Squibb; Braine-l'Alleud Belgium

12. University Hospital Bellvitge; Barcelona Spain

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.13830/fullpdf

Reference50 articles.

1. United States Renal Data System 2014 Annual Data Report. Chapter 6: Transplantation 2014 http://www.usrds.org/2014/view/v2_06.aspx

2. 2012 Annual Data Report: Kidney;Matas;Am J Transplant,2014

3. Kidney and pancreas transplantation in the United States, 1999-2008: The changing face of living donation;Axelrod;Am J Transplant,2010

4. Renal transplantation from extended criteria cadaveric donors: Problems and perspectives overview;Audard;Transpl Int,2008

5. Outcomes of transplantation using kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 2005;Collins;Transplantation,2009

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppression in Kidney Transplant Recipients: An Update for the General Nephrologist;Advances in Kidney Disease and Health;2024-09

2. Evaluation of Torque Teno Virus DNA Load as a Predictive Biomarker in Kidney Transplant Recipients Converted from Calcineurin Inhibitors to Belatacept;Kidney International Reports;2024-06

3. Long-term Safety in Epstein–Barr Virus–Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry;Transplantation Direct;2024-05-17

4. Use of a Belatacept-based Immunosuppression for Kidney Transplantation From Donors After Circulatory Death: A Paired Kidney Analysis;Transplantation Direct;2024-04-11

5. Kidney transplants from elderly donors: what we have learned 20 years after the Crystal City consensus criteria meeting;Journal of Nephrology;2024-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3